The BRCT domain from the homologue of the oncogene PES1 in Leishmania major (LmjPES) promotes malignancy and drug resistance in mammalian cells
Keywords:
Leishmaniasis
Cancer
BRCT domain
LmjPES1
Drug resistance
Gene expression
Cell survival
Oncogene and cellular proliferation
Note:
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Citation:
Larrea-Leoz, M. (María Esther); Fernández-Rubio, C. (Celia); Peña-Guerrero, J.; et al. "The BRCT domain from the homologue of the oncogene PES1 in Leishmania major (LmjPES) promotes malignancy and drug resistance in mammalian cells". International Journal of Molecular Sciences. 23 (21), 2022, 13203
Larrea-Leoz, M. (María Esther); Fernández-Rubio, C. (Celia); Peña-Guerrero, J.; et al. "The BRCT domain from the homologue of the oncogene PES1 in Leishmania major (LmjPES) promotes malignancy and drug resistance in mammalian cells". INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23 (21), 2022, 13203
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.